Abstract
A method and apparatus for detection of pteridine levels in a biological sample using CE-LIF which is useful for early cancer screening involving fully oxidizing pteridine compounds in a sample such as a urine sample, subjecting to CE-LIF to assess compound concentration, and compare to expected levels in for healthy or cancer-bearing patients.
Recommended Citation
Y. Ma and S. Gibbons, "Method and Apparatus for Cancer Screening," U.S. Patents, Dec 2015.
Department(s)
Chemistry
Patent Application Number
US12/971,194
Patent Number
US9207205B2
Document Type
Patent
Document Version
Final Version
File Type
text
Language(s)
English
Rights
© 2010 The Curators of the University of Missouri, All rights reserved.
Publication Date
08 Dec 2015
Comments
23 Jun 2011: Publication of US20110147217A1